Clinical Trial Update: PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

View source ↗

Summary

A completed observational genetics study (PROGENI) examining LRRK2 in Parkinson disease, conducted by Indiana University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Indiana University | Conditions: Parkinson Disease | Status: COMPLETED